Handelsinvest Investeringsforvaltning »

Intra Cellular Therapies shares owned by Handelsinvest Investeringsforvaltning

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Handelsinvest Investeringsforvaltning from 13F filings

Historical chart of Handelsinvest Investeringsforvaltning investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Handelsinvest Investeringsforvaltning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Handelsinvest Investeringsforvaltning

Quarter filed Position value Share count Share price at filing
2024-03-31 $223k 3.2k 69.32
2023-12-31 $350k 4.9k 71.62

More positions owned by Handelsinvest Investeringsforvaltning

Microsoft Corp Common Stock (MSFT)
NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Alphabet Common Stock (GOOGL)
Meta Platforms Common Stock (META)
JPMorgan Chase & Co Common Stock (JPM)
Eli Lilly & Co Common Stock (LLY)
Broadcom Common Stock (AVGO)
Visa Common Stock (V)
Mastercard Common Stock (MA)
UnitedHealth Group Common Stock (UNH)
Procter & Gamble Co/The Common Stock (PG)
Merck & Co Common Stock (MRK)
Alphabet Common Stock (GOOG)

View all positions for Handelsinvest Investeringsforvaltning

Top funds holding Intra Cellular Therapies

Vanguard Group
Daniel D. Thurber
Bellevue Group
venBio Select Advisor
Jpmorgan Chase & Co
Alliancebernstein
Franklin Resources
Wellington Management Company
Jennifer Ranahan
ClearBridge Advisors
Holocene Advisors
T. Rowe Price Associates
Norges Bank Investment Management
Charles Schwab Investment Management
Lord, Abbett & Co

View all funds holding Intra Cellular Therapies